AR086279A1 - Tapones lagrimales para la liberacion controlada de agentes terapeuticos - Google Patents

Tapones lagrimales para la liberacion controlada de agentes terapeuticos

Info

Publication number
AR086279A1
AR086279A1 ARP120101583A ARP120101583A AR086279A1 AR 086279 A1 AR086279 A1 AR 086279A1 AR P120101583 A ARP120101583 A AR P120101583A AR P120101583 A ARP120101583 A AR P120101583A AR 086279 A1 AR086279 A1 AR 086279A1
Authority
AR
Argentina
Prior art keywords
plugs
tear
labor
therapeutic agents
controlled release
Prior art date
Application number
ARP120101583A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR086279A1 publication Critical patent/AR086279A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los insertos lagrimales, tales como los tapones lagrimales, se pueden usar para el suministro de medicación en el ojo. El tapón incluye una porción de cuerpo que tiene un tamaño para pasar a través de un punto lagrimal y colocarse dentro de un canalículo lagrimal del párpado. El tapón puede contener un núcleo, o reservorio, por lo menos parcialmente dentro de la parte del cuerpo que comprende un agente terapéutico configurado para controlar la liberación pulsátil en el ojo.
ARP120101583A 2011-05-06 2012-05-04 Tapones lagrimales para la liberacion controlada de agentes terapeuticos AR086279A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161483157P 2011-05-06 2011-05-06
US13/409,210 US9301874B2 (en) 2011-05-06 2012-03-01 Punctal plugs for controlled release of therapeutic agents

Publications (1)

Publication Number Publication Date
AR086279A1 true AR086279A1 (es) 2013-12-04

Family

ID=47090724

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101583A AR086279A1 (es) 2011-05-06 2012-05-04 Tapones lagrimales para la liberacion controlada de agentes terapeuticos

Country Status (4)

Country Link
US (1) US9301874B2 (es)
AR (1) AR086279A1 (es)
TW (1) TW201304758A (es)
WO (1) WO2012154427A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072588B2 (en) * 2011-10-03 2015-07-07 Alcon Research, Ltd. Selectable varied control valve systems for IOP control systems
WO2016176252A1 (en) * 2015-04-27 2016-11-03 Khan Taj H Biosensor canalicular stent

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626940A (en) 1969-05-02 1971-12-14 Alza Corp Ocular insert
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3993071A (en) 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3826258A (en) 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US3962414A (en) 1972-04-27 1976-06-08 Alza Corporation Structured bioerodible drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4923699A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
US6020445A (en) 1997-10-09 2000-02-01 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US5962548A (en) 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6196993B1 (en) 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6306114B1 (en) 1998-06-16 2001-10-23 Eagle Vision, Inc. Valved canalicular plug for lacrimal duct occlusion
US6099852A (en) 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
TWI542338B (zh) 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
US8808257B2 (en) * 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
US20110251568A1 (en) 2010-04-08 2011-10-13 Beeley Nathan R F Punctal plugs for controlled release of therapeutic agents

Also Published As

Publication number Publication date
TW201304758A (zh) 2013-02-01
US20120283669A1 (en) 2012-11-08
WO2012154427A1 (en) 2012-11-15
US9301874B2 (en) 2016-04-05

Similar Documents

Publication Publication Date Title
AR084677A1 (es) Tapones lagrimales para la liberacion controlada de agentes terapeuticos
AR084478A1 (es) Tapones lagrimales con liberacion direccional
AR084713A1 (es) Tapon lagrimal que contiene formulacion de farmaco
UY32537A (es) Tapones lagrimales
AR121843A2 (es) Formulación oftálmica y método para mejorar la presbicia
AR084697A1 (es) Tapones lagrimales con mecanismo de liberacion de farmacos continuo o pulsatil
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
DOP2016000061A (es) Nanopartículas poliméricas terapéuticas y métodos para su elaboración y uso
TN2016000162A1 (en) Eye device.
CL2017001117A1 (es) Métodos para tratar enfermedades oculares.
CL2017001188A1 (es) Métodos y formulaciones para tratar enfermedades vasculares de los ojos.
CR20150189A (es) Nanopartículas terapéuticas que comprenden un agente terapéutico y métodos para realizarlas y usarlas
DOP2017000156A (es) Derivados de glucagón con estabilidad mejorada
CL2015000699A1 (es) Métodos para tratamiento de cáncer.
AR054683A1 (es) Capuchon para dispositivos para la administracion de farmacos
EA201691193A1 (ru) Система доставки лекарственных средств
MX2013000661A (es) Sistema de susministro de farmacos oculares.
CR20180228A (es) Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma
AR096893A1 (es) Composición de un antagonista del factor de crecimiento del endotelio vascular (vegf, por sus siglas en inglés) para tratamiento de retinoterapia del prematuro
CL2017000120A1 (es) Composiciones en suspensión de ciclosporina a para inyecciones subconjuntivales y perioculares
CO6960545A2 (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retención de lágrimas
PH12016501965A1 (en) S1p modulator immediate release dosage regimen
EP3838328A3 (en) Drug delivery devices
BR112014025737A2 (pt) método para administrar um agente terapêutico, método para prevenir a entrada de um agente terapêutico, método para modular a velocidade de liberação de um agente terapêutico, agente terapêutico, formas de dosagem, método de tratamento de uma doença e kit de partes
CL2012002038A1 (es) Metodo para reducir la presion intraocular que comprende la administracion en forma topica de una composicion farmaceutica que comprende 4-bromo-5-(2-imidazolin-2-ilamin)benzimidazol, en donde el ojo afectado tiene una presion intraocular inferior a la de la linea base; y articulo de elaboracion que comprende a dicha composicion.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee